Navigation Links
CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
Date:10/17/2008

ns to incorporate a number of features in the study design intended to manage the issues that can confound antidepressant clinical trial results."

Depression clinical trial expert Dr. Norman Rosenthal, Medical Director of Capital Clinical Associates and one of the lead investigators of the Tyrima Phase II study noted, "The CeNeRx team gets high marks for designing a first-class clinical trial. Recent efforts to test new antidepressants have encountered technical difficulties, such as a high placebo effect, which the current trial works hard to avoid. I am optimistic that the present trial should enable us to assess the potential of Tyrima as a potentially valuable new antidepressant agent."

Similar to the mechanism of conventional monoamine oxidase A inhibitors (MAOI), the triple-action mechanism of Tyrima elevates the levels of three key neurotransmitters (serotonin, norepinephrine and dopamine) that positively affect mood and anxiety, compared to the one or two neurotransmitters addressed by most current antidepressant drugs. This triple-action mechanism has the potential to provide improved antidepressant efficacy in some patients, while the selectivity and reversibility of Tyrima are expected to reduce or eliminate the risk of food-associated cardiovascular side effects of conventional MAOIs.

"A substantial subset of patients suffering from depression responds much better to treatment with MAOIs than other therapies, yet the risk of food-associated cardiovascular side effects of conventional MAOIs have greatly restricted their use, to the disadvantage of our patients," said Dr. Alexander Bodkin, a Tyrima Phase II investigator and Director of the Clinical Psychopharmacology Research Program at McLean Hospital of Harvard Medical School. "A novel agent such as Tyrima with proven MAOI activity in the CNS and a good safety and tolerability profile would be a valuable option for the many patients whose depression is refractory to treatment with cu
'/>"/>

SOURCE CeNeRx BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
2. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
3. InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
4. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
5. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
6. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
7. Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation
8. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
9. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
10. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
11. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 26, 2015 ViiV Healthcare, Aurobindo ... announced today that Aurobindo Pharma has submitted an Abbreviated ... Approval, to the Food and Drug Administration (FDA), for ... for a generic version of dolutegravir, less than two ... in the United States . ...
(Date:5/26/2015)... May 26, 2015  LabStyle Innovations Corp. ... Solution, announced today that in partnership with ... Maccabi Healthcare, it has launched  the comprehensive ... Maccabi,s advanced Telecare unit (MOMA). The Dario™ ... that enables remote treatment for diabetes aiming ...
(Date:5/26/2015)... 26, 2015  Respiratory Motion, Inc. – Research ... Meeting of the Japanese Society of Anesthesiologists shows ... in hospitals miss critical early indicators of impending ... findings conclude that respiratory volume monitoring using the ... consistently protects patients than traditional capnography and pulse ...
Breaking Medicine Technology:ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 2Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 3Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 4Eight Studies Find Capnography, Pulse Oximetry Can Leave Patients at Risk for Life-Threatening Respiratory Depression 5
... This Week , a leading industry publication, has honored Amedica®/US ... for Spine Care in 2010 . Amedica/US Spine, ... unique silicon nitride (SiN) ceramic technologies, received recognition in the ... Valeo® AL Lumbar Spacer and Best New Technology in ...
... CareTech Solutions, an information technology and Web products ... hospitals, announced today that the Detroit Medical Center ... document imaging solution, iDoc™, for the eight-facility integrated ... "As the largest healthcare provider in southeast Michigan, ...
Cached Medicine Technology:Two Amedica®/US Spine® Implant Products Receive Best New Technology Awards from Orthopedics This Week 2Detroit Medical Center Chooses CareTech Solutions' Document Imaging System 2
(Date:5/26/2015)... 27, 2015 Readers who struggle with ... help in author Chester Litvin ’s new book, ... Code” (published by Trafford Publishing). , Litvin, who is ... stimulating the brain. This book will guide readers through ... sensory brain cells . He shares his patented ...
(Date:5/26/2015)... 2015 Forex Income Boss is a ... their results trading in the foreign exchange market. The ... utilizes 10 customer indicators to help traders locate perfect ... usual, Russ Horn's latest trading system is the talk ... reports Tiffany Hendricks, senior product reviewer at HonestyFirstReview.com. "While ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Dermatologic surgeons ... in 2014, according to survey results released today by ... in skin cancer treatments and several cosmetic categories, 2014 ... but remained steady overall compared to 2013 figures. ... cancer treatments ranked as the most-performed procedure (3.08 million) ...
(Date:5/26/2015)... 2015 Over 700 doctors, nutritionists, nurses, ... to the secretaries of the U.S. Department of Agriculture ... urging them to embrace the 2015 Dietary Guidelines Advisory ... for human health, economic prosperity, and our nation’s food ... the letter, including: Dr. David Katz, founding director of ...
(Date:5/26/2015)... NM (PRWEB) May 26, 2015 ... providing New Mexico patients with MRI, Ultrasound, and ... by the American College of Radiology. The center ... CT services. , In order to be ... a variety of qualifications including personnel qualifications, adequacy ...
Breaking Medicine News(10 mins):Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 2Health News:Chester Litvin’s New Book Offers ‘Tune-Up’ for Brain Cells 3Health News:Forex Income Boss - Review Of Russ Horn's New FX Trading System Released 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 2Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 3Health News:New ASDS Survey: 9.5 Million Treatments Performed in 2014 4Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 2Health News:700 Doctors, Health Professionals, Including the American College of Lifestyle Medicine, Support Dietary Guidelines Message to Eat Less Meat, More Plants 3
... analysis has found that a considerable proportion of ... benefit from palliative radiation therapy (radiotherapy) despite spending ... early online in CANCER , a peer-reviewed ... indicates that greater efforts are needed to tailor ...
... Microscope depicts on its screen the few nanometer thick ... crisscrossing the surface on which they are deposited. The ... that they can self assemble into complex ribbon-like twisted ... of Fribourg have teamed up to take Atomic Force ...
... ... selected DOMA Technologies to provide Medical Coding Services to select Northwest ... using their iCodeRx SaaS application and ensure that coding services meet ... and assemble medical record data and assign diagnoses and procedure codes ...
... legs seen in many patients under 55: study , ... may be much more common in younger American adults and ... The disease causes a narrowing in blood vessels that carry ... to symptoms that include pain and cramping in the legs ...
... ... robust new website that highlights the practice’s state-of-the-art treatments and gentle, personalized approach. Drs. Bradley ... and engaging look at all the practice has to offer. , ... San Diego, CA (Vocus) April 10, 2010 -- Two ...
... ... equivalent of 10,000 laser targeted marketing postcards to all of your patient,s friends for ... ... the easiest chiropractic marketing can be done right now in the office for ...
Cached Medicine News:Health News:Terminal cancer patients do not receive appropriate radiation therapy 2Health News:The assembly of protein strands into fibrils 2Health News:Army Awards Remote Medical Coding Contract to DOMA Technologies 2Health News:Severe Arterial Disease Found in Younger Adults 2Health News:San Diego Cosmetic Dentists Launch New Website and Rejuvenate Online Image 2Health News:San Diego Cosmetic Dentists Launch New Website and Rejuvenate Online Image 3Health News:Chiropractic Traffic CEO Matt Prados Releases the Easiest and Fastest Free Chiropractic Marketing Method Known to Man 2
... Ulti-Mist™ HME product line has the right ... to adults and from intubated patients to ... humidification for both anesthesia and critical care ... provide maximum protection for patients and staff ...
... The Ulti-Mist™ HME product line has ... from pediatrics to adults and from intubated ... offer superior humidification for both anesthesia and ... and HME/Filters provide maximum protection for patients ...
... HME product line has the right product ... adults and from intubated patients to patients ... for both anesthesia and critical care applications., ... maximum protection for patients and staff members. ...
... condenser humidifiers (HCH) capture the patient`s exhaled ... the inspired gas. Small and compact, they ... hygroscopic benefits. Depending on the tidal volume ... model., ,The adult HCH is ideal ...
Medicine Products: